News
Treatments for acromegaly, edema, HSCT-associated thrombotic microangiopathy, multiple sclerosis, and spinal muscular atrophy are under review.
While most cases of bug bites can be managed at home, some symptoms are more serious and should prompt patients to seek ...
Topeline data were announced from a phase 3 trial evaluating SB-01 for intradiscal treatment of patients with CLBP associated with DDD.
Large postpandemic prevalence increases were seen in functional dyspepsia and irritable bowel syndrome. HealthDay News — The prevalence of disorders of the gut-brain interaction (DGBI) increased from ...
Your patient with gout is undergoing evaluation prior to initiation of urate-lowering therapy (ULT). According to the American College of Rheumatology (ACR) guidelines, anti-inflammatory prophylaxis ...
HealthDay News — The U.S. Preventive Services Task Force (USPSTF) recommends screening adults for unhealthy alcohol use and providing brief behavioral counseling interventions for those engaged in ...
HealthDay News — Each year, nearly 74,000 children are born with hepatitis C virus (HCV) around the world, according to a study published online July 23 in The Lancet Gastroenterology and Hepatology.
GLP-1 RA use increases risk for nonarteritic anterior ischemic optic neuropathy compared with other second-line antidiabetic medications.
The FDA has approved the SetPoint System, a neuroimmune modulation device, for the treatment of adults with moderately to ...
Long COVID risk was linked to financial hardship, food insecurity, less than a college education, and lack of social support.
Affluence and racial makeup of neighborhoods were associated with incidence rate ratios of breast and cervical cancer.
HealthDay News — Women with multiple sclerosis (MS) are less likely to receive disease-modifying therapies (DMTs) than men, according to a study published online July 30 in Neurology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results